NCT06362369 2026-04-13A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT06305962 2026-02-19177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, LtdPhase EARLY_PHASE1 Recruiting30 enrolled